Abivax
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7-11 Boulevard Haussmann, Paris, Ile-de-...Phone Number
+33 153830963Website
www.abivax.comRevenue
<$5 MillionStock Symbol
ABVXIndustry
About Abivax
Abivax is a clinical-stage biotechnology company focused on advancing human health by regulating the immune response through microRNA technology. Their lead drug candidate, obefazimod, is an investigational small molecule designed to treat chronic inflammatory diseases, starting with ulcerative colitis. The company aims to develop and commercialize innovative therapies that stabilize immune responses and improve patient outcomes. Abivax is also exploring additional inflammatory indications and has a proprietary chemical library for future research opportunities.Explore more
Abivax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Abivax Tech Stack
A closer look at the technologies used by Abivax
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abivax
Sign Up For FreeTo access detailed company insights
Abivax is a clinical-stage biotechnology company focused on advancing human health by regulating the immune response through microRNA technology. Their lead drug candidate, obefazimod, is an investigational small molecule designed to treat chronic inflammatory diseases, starting with ulcerative colitis. The company aims to develop and commercialize... Read More
